1414 Raleigh Road
United States - Map
POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and pain related conditions in the United States. The companys products include Treximet for acute treatment of migraine attacks with or without aura in adults; and VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing non-steroidal anti-inflammatory drugs (NSAID)-associated gastric ulcers. The company also provides PA32540 for secondary prevention of cardiovascular and cerebrovascular disease in patients at risk for gastric ulcers. It has collaborations with GlaxoSmithKline for the development and commercialization of proprietary combinations of a triptan and a long-acting NSAID; and with AstraZeneca AB for the development and commercialization of proprietary fixed dose combinations of the proton pump inhibitor esomeprazole magnesium with the NSAID naproxen. The company was founded in 1996 and is headquartered in Chapel Hill, North Carolina.
|POZEN Inc.’s ISS Governance QuickScore as of Mar 1, 2014 is 10. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 10; Compensation: 10.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Dr. John R. Plachetka Pharm D.,
Co-Founder, Chairman, Chief Exec. Officer and Pres
|Mr. William L. Hodges CPA,
Chief Financial Officer and Sr. VP of Fin. & Admin.
|Ms. Gilda M. Thomas J.D.,
Sr. VP, Gen. Counsel and Sec.
|Dr. John G. Fort M.D., MBA,
Chief Medical Officer
|Mr. John E. Barnhardt CPA,
Principal Accounting Officer and VP of Fin. & Admin.
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|